(Total Views: 541)
Posted On: 11/04/2021 6:14:47 PM
Post# of 153930
RLFTF goes up 15% today, for safety data only, as CYDY is flat from 2 outstanding PRs, cancer and NASH!!!! (?????) Are people thinking with their toe nails????
CYDY Manipulation? SEC allows hedge fund perpetual control of stock's share pricing? Hedge funds control crypto prices up and down at will????
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (" NRx "
, has issued a press release announcing a new safety update on aviptadil, which is being tested in the ACTIV-3b Critical Care Phase 3 study sponsored by the National Institutes of Health. According to the press release, in its third scheduled analysis, the study's Independent Data Safety Monitoring Board found no new safety concerns after reviewing a total of more than 300 patients and recommended continued enrollment to target 640 patients. The related NRx press release can be accessed through the following link.
https://www.theglobeandmail.com/investing/mar...s/3431829/
CYDY Manipulation? SEC allows hedge fund perpetual control of stock's share pricing? Hedge funds control crypto prices up and down at will????
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (" NRx "
, has issued a press release announcing a new safety update on aviptadil, which is being tested in the ACTIV-3b Critical Care Phase 3 study sponsored by the National Institutes of Health. According to the press release, in its third scheduled analysis, the study's Independent Data Safety Monitoring Board found no new safety concerns after reviewing a total of more than 300 patients and recommended continued enrollment to target 640 patients. The related NRx press release can be accessed through the following link. https://www.theglobeandmail.com/investing/mar...s/3431829/
(2)
(0)
